Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now
Merrill Lynch recently highlighted sectors it considers a good opportunity now that are likely to outperform in the near term, and the sector that rated highest was biotechnology.
Merrill Lynch recently highlighted sectors it considers a good opportunity now that are likely to outperform in the near term, and the sector that rated highest was biotechnology.
These four top stocks have not gone up in tandem with oil pricing, and some are offering outstanding entry points. They are outstanding long-term buys for growth portfolios looking for income.
These six incredible companies dominate the aerospace and defense sector and should continue to do so in the years to come.
The technology sector is not cheap, but companies with solid recurring revenues can fare well in an environment in which taxes are lower and growth in the economy is solid.
Income-minded investors with a higher risk tolerance for dividend-paying equities can still find solid value even in today’s pricey market. These five stocks come with outstanding regular and dependable dividends of at least 4%.
Jefferies highlights the firm's top growth stocks to buy each week, and recently four top biotech stocks made the cut. They all make good sense now, and all have outstanding upside potential.
These five tech laggards have big upside to the Merrill Lynch price targets and also offer investors perhaps a more comfortable entry point.
Here are five stocks for aggressive accounts that look to get share count leverage on companies that have sizable upside potential.
As we are in a late cycle market, it makes sense to look for value and for some safety, and the analysts at Oppenheimer might be on to the sector that has both.
A series of new Stifel research reports focus on three biotech companies that have upcoming clinical data that could prove to be huge.
These companies pay reliable dividends, and if you can stand the potential roller coaster ride, you may have a nice steady stream of hefty income.
These three top additions to the Merrill Lynch International portfolio look like solid plays for investors, especially those looking for growth and a dependable dividend.
Now may be a good time to shift from growth to value to anticipate a continued rise in rates. Jefferies continues to prefer value stocks over growth as the group is showing solid earnings…
Three stocks rated Outperform at Baird are what they call 5G derivatives due to their exposure to potential business for the buildout. All are good picks for speculative accounts looking for alpha-generating ideas.
With automotive and industrial applications growing fast, smartphones growing ever more functional and video gaming and data center growth skyrocketing, the future remains very positive for semiconductor stocks.
In a new research report, Baird analysts highlighted some of the top companies from the Shop.org conference, and three stocks are rated Outperform at the firm.
The venerable Dow Jones industrial average is having a solid year, up just under 6%, but many of the top names in the index are down for 2018 and may be offering investors enticing…
In a new research report, Baird analysts highlighted some of the top companies from the Shop.org conference, and three stocks are rated Outperform at the firm.
These top payment services stocks have been on a roll, and these three sector leaders are very hard to challenge.
A new research report from Goldman Sachs makes some observations on companies that participated in the firm's Communacopia Conference, and the firm is quite positive on four of the stocks.